# Lithium As a Treatment to Prevent Impairment of Cognition in Elders

> **NCT03185208** · PHASE4 · COMPLETED · sponsor: **Ariel Gildengers, MD** · enrollment: 83 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Lithium Carbonate
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03185208
- **Lead sponsor:** Ariel Gildengers, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-02
- **Primary completion:** 2024-08-06
- **Final completion:** 2024-08-06
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03185208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03185208, "Lithium As a Treatment to Prevent Impairment of Cognition in Elders". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03185208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*